A California-based biotech company is turning heads on Wednesday morning after it was announced that the company received FDA approval for the supplemental new drug application...

To read the full story on AllPennyStocks.com, click here.

Heron Therapeautics (NASDAQ:HRTX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Heron Therapeautics
Heron Therapeautics (NASDAQ:HRTX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Heron Therapeautics